Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

计划入组 57 人 · 首次发布于 2017 年 6 月 29 日

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

计划入组 16 人 · 首次发布于 2017 年 8 月 3 日

Patients Treated for SCID (1968-Present)

计划入组 1,007 人 · 首次发布于 2011 年 5 月 2 日

ABI-1968

SBX-1968

Namitecan

C₂₃H₂₂N₄O₅

Iceni Gold Ltd

HAMILTON CDN BK MEAN RVSON IDX ETF UNIT

United States

Cspc-Nbp Pharmaceutical Co., Ltd.

China

Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity

Neurocrine Biosciences Initiates Phase 1 Trial for Novel CRF2 Agonist NBIP-2118 in Obesity Treatment

Neurocrine Biosciences Initiates Phase 1 Trial for Long-Acting CAH Treatment NBIP-01435